Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 17, 2021

SELL
$79.17 - $111.47 $8.5 Million - $12 Million
-107,424 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$81.91 - $134.94 $8.8 Million - $14.5 Million
107,424 New
107,424 $11.1 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $442M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.